Lishan Aklog

Insider Reports History

Entity
Individual
Location
420 Lexington Avenue, Suite 300, New York, NY
Signature
/s/ Michael A. Gordon, by power of attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Lishan Aklog:

Stock Role Class Num Shares Value Price $ Report Date Ownership
PAVmed Inc. Chairman and CEO, Director Common stock 4.46M $2.78M $0.62 Mar 28, 2022 By Pavilion Venture Partners LLC
Lucid Diagnostics Inc. Chief Executive Officer, Director Common stock 1.17M $1.64M $1.40 May 7, 2024 Direct
PAVmed Inc. Chairman and CEO, Director Common stock 176K $110K $0.62 Mar 28, 2022 Direct
PAVmed Inc. Chairman and CEO, Director Common stock 20K $12.5K $0.62 Mar 28, 2022 By HCFP/AG LLC
PAVmed Inc. Chairman and CEO, Director Common stock 2.3K $1.44K $0.62 Mar 28, 2022 by daughter
PAVmed Inc. Chairman and CEO, Director Common stock 2.28K $1.42K $0.62 Mar 28, 2022 by son
CONTRAFECT Corp Director Options (Right to Buy) 42K May 17, 2022 Direct

Insider Reports Filed by Lishan Aklog

Symbol Company Period Transactions Value $ Form Type Date Filed Role
LUCD Lucid Diagnostics Inc. May 7, 2024 1 $0 4 May 8, 2024 Chief Executive Officer, Director
CFRX CONTRAFECT Corp May 17, 2022 1 $141K 4 May 18, 2022 Director
PAVM PAVmed Inc. Mar 28, 2022 1 -$94K 4 Apr 11, 2022 Chairman and CEO, Director
LUCD Lucid Diagnostics Inc. Feb 18, 2022 1 $0 4 Feb 23, 2022 Chief Executive Officer, Director
PAVM PAVmed Inc. Feb 18, 2022 1 $0 4 Feb 23, 2022 Chairman and CEO, Director, 10%+ Owner
LUCD Lucid Diagnostics Inc. Jan 7, 2022 1 $0 4 Jan 10, 2022 Chief Executive Officer, Director
LUCD Lucid Diagnostics Inc. Oct 13, 2021 0 $0 3 Oct 13, 2021 Chief Executive Officer, Director
CFRX CONTRAFECT Corp May 18, 2021 1 $0 4 May 20, 2021 Director